13F Holdings
中文EN

RVP RETRACTABLE TECHNOLOGIES INC

Surgical & Medical Instruments & Apparatus · NYSE · SEC CIK 946563 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY0.1%
TTM net income YoY5.3%
TTM EPS YoY4.5%
Revenue 3-yr CAGR-3.3%
Net income 3-yr CAGR—

Margins

Gross margin-5.2%
Operating margin-61.1%
Net margin-16.1%
FCF margin—
EBITDA margin-40.4%

Returns

ROE-8.3%
ROA-4.3%
ROIC (approx.)-25.6%
Asset turnover0.27x

Leverage & solvency

Liabilities / assets49.2%
Debt / equity0.00x
Current ratio4.54x
Interest coverage-299.43x

Cash quality & payout

Operating cash flow / net income0.65x
Accruals ratio-1.5%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$38.27M$33.05M$43.60M$94.82M$188.38M
Cost of revenue$38.22M$34.08M$34.49M$66.57M$93.03M
Gross profit$47,046-$1.03M$9.11M$28.25M$95.35M
R&D expense$675,567$673,944$581,172$525,727$901,381
SG&A expense$12.77M$13.56M$14.31M$24.04M$17.38M
Operating income-$21.18M-$21.11M-$11.49M-$852,976$72.60M
Interest expense$87,904$122,500$152,166$170,651$227,183
Pretax income-$12.27M-$3.52M-$8.92M$5.16M$74.95M
Income tax$291,293$8.37M-$1.91M$83,870$18.89M
Net income-$12.57M-$11.89M-$7.01M$5.08M$56.06M
EBITDA-$13.41M-$13.54M-$3.96M$3.75M$73.85M
EPS (basic)-0.43-0.40-0.240.151.65
EPS (diluted)-0.43-0.40-0.240.151.63
Weighted avg. shares (diluted)29.94M29.94M29.94M32.96M34.24M
Balance sheet
Cash & equivalents$2.59M$4.24M$12.67M$19.72M$29.16M
Receivables$7.90M$7.79M$10.67M$4.84M$34.86M
Inventory$17.19M$19.19M$17.58M$20.68M$20.59M
Current assets$63.08M$73.27M$77.65M$88.81M$104.51M
PP&E, net$79.18M$87.35M$93.48M$100.15M$87.93M
Total assets$142.63M$160.72M$179.67M$195.67M$206.30M
Current liabilities$9.60M$8.78M$9.38M$12.14M$35.32M
Short-term debt—$332,480$303,991$285,954$289,114
Long-term debt$895,645$900,042$1.23M$1.53M$1.81M
Total debt$895,645$1.23M$1.54M$1.82M$2.10M
Total liabilities$68.26M$73.55M$80.38M$89.13M$107.14M
Shareholders' equity$74.38M$87.17M$99.29M$106.54M$99.17M
Net debt-$1.69M-$3.00M-$11.13M-$17.90M-$27.06M
Shares outstanding29.94M29.94M29.94M29.94M33.48M
Cash flow statement
Operating cash flow-$7.06M-$11.56M$2.77M$16.77M$32.79M
Capital expenditure—$1.44M$852,979$16.83M$58.37M
Free cash flow—-$13.00M$1.91M-$61,949-$25.57M
Investing cash flow$5.98M$3.66M-$10.76M-$31.20M-$63.04M
Financing cash flow-$567,321-$535,433$941,640$4.99M$41.84M
Depreciation & amortization$7.77M$7.57M$7.53M$4.60M$1.26M
Stock-based compensation—$0$0$10.13M$3.66M
Share buybacks———$7.62M$5.27M

Free plan shows the latest 5 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.